Mesoblast Limited ( MESO) - Stock Earnings
MESO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -20.1 million USD | 25.7 million USD |
| 2026Q1 | -8.7 million USD | 34.5 million USD |
| 2026Q2 | -8.7 million USD | 35.0 million USD |
MESO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -88.0 million USD | 5.9 million USD |
| 2025 | -102.1 million USD | 17.2 million USD |
| 2026 | -57.8 million USD | 120.8 million USD |
| 2026 Est. | — | — |
MESO
Price: $13.87
52 week price:
Earnings Per Share: -0.44 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 45251
Ebitda: -19.5 millionMarket Capitalization: 1.8 billion